Sleep Lab Thresholds Under Scrutiny: When Should Children With Muscle Disease Start Ventilation?

Deciding when a child with a neuromuscular disease should begin non-invasive ventilation is one of the most consequential judgment calls in pediatric sleep medicine. Start too late, and the child may endure years of unrecognized nocturnal hypoventilation, fragmented sleep, morning headaches, and insidious decline in daytime function. Start too early, and families face the burden of nightly mask therapy, equipment costs, and the psychological weight of medicalizing a child’s bedtime without a clear payoff. A recent letter to the editor published in the Journal of Clinical Sleep Medicine by Abdul Basit Munir, Haider Imran, and Nashmia Faraz of Foundation University Medical College in Islamabad takes aim at exactly this dilemma, examining the methodological and clinical considerations behind polysomnographic criteria proposed for guiding the initiation of non-invasive ventilation in children with neuromuscular diseases.

The letter responds to a study by Dannenberg and colleagues, published earlier in the same journal, that set out to establish polysomnographic criteria for starting non-invasive ventilation in children with neuromuscular disease. That original investigation addressed a genuine gap. For decades, clinicians have relied on a patchwork of guidelines, expert consensus, and institutional habit when interpreting sleep studies in this population, and the thresholds used to declare a sleep study abnormal have varied widely between centers. Any serious attempt to standardize those thresholds therefore deserves attention, and the letter writers acknowledge the value of the effort even as they probe its foundations.

Polysomnography, the overnight sleep test at the center of this debate, records a remarkable array of physiological signals: brain electrical activity through electroencephalography, eye movements that mark rapid eye movement sleep, muscle tone at the chin and limbs, airflow at the nose and mouth, respiratory effort through chest and abdominal belts, and blood oxygen saturation through pulse oximetry, alongside carbon dioxide measurement where available. In healthy children, breathing during sleep is remarkably stable, particularly in non-REM stages. In children with weakened respiratory muscles, however, the physiology changes in characteristic ways, and understanding those changes is essential to understanding why the criteria debate matters so much.

The key vulnerability lies in REM sleep. During REM, the body’s skeletal muscles, with the exception of the diaphragm and the extraocular muscles, lose their tone as part of the brainstem’s protective mechanism that prevents sleepers from acting out dreams. In a child whose intercostal muscles and accessory breathing muscles are already weakened by conditions such as Duchenne muscular dystrophy or spinal muscular atrophy, this REM-related muscle atonia can leave the diaphragm working alone against the resistance of a floppy chest wall. The result is shallow, inefficient breathing confined to REM periods, with oxygen saturation drifting downward and carbon dioxide accumulating, often without any dramatic apneas to catch an automated scoring algorithm’s attention. This pattern, sometimes called REM-related hypoventilation, is typically the earliest sleep-breathing abnormality in progressive neuromuscular disease.

Because the earliest abnormalities are subtle and stage-specific, the choice of polysomnographic thresholds carries enormous weight. Should the trigger for considering ventilation be a certain number of oxygen desaturations per hour, a defined percentage of sleep time spent below a saturation cutoff, an elevated transcutaneous or end-tidal carbon dioxide level, or some combination of these? Each option has methodological trade-offs. Desaturation indices borrowed from adult obstructive sleep apnea practice may miss the slow, sustained gas exchange deterioration typical of neuromuscular disease, where the abnormality is hypoventilation rather than discrete apneic events. Carbon dioxide measures, though more directly relevant to hypoventilation, are technically finicky in children, prone to signal drift and displacement, and not uniformly available across sleep laboratories.

These technical uncertainties form one strand of the letter’s argument. The authors raise methodological considerations about how criteria derived from a particular patient population and a particular set of recording practices can be generalized. Reference values for pediatric sleep studies differ by age, and children with neuromuscular disease span a wide developmental range, from toddlers with congenital myopathies to adolescents with advanced dystrophinopathies. A single threshold applied across that spectrum risks misclassifying both the youngest patients, whose normal physiology differs from school-age children, and those with slowly versus rapidly progressive conditions, whose trajectories of respiratory decline follow very different clocks.

The clinical considerations the authors emphasize are equally important. Polysomnography captures a single night, a snapshot that may not represent a child’s typical sleep, particularly in an unfamiliar laboratory environment where the first-night effect can suppress REM sleep and mask the very abnormalities clinicians are hunting for. A child whose REM time is curtailed on the study night may appear deceptively normal. Conversely, transient illness, nasal congestion, or anxiety can exaggerate abnormalities. Serial monitoring, careful correlation with daytime symptoms such as morning headaches, excessive sleepiness, poor school performance, and frequent nocturnal awakenings, and attention to trends over time may matter as much as any single numeric cutoff.

The stakes of getting these criteria right extend well beyond the sleep laboratory. Long-term non-invasive ventilation reshapes family life. Research on children with neuromuscular diseases who use ventilators, including work by Johannsen and colleagues cited in the letter, has examined the impact of long-term ventilator use on health-related quality of life and the mental health of affected children and their families, highlighting the need for a revised perspective on how these burdens are weighed. Initiating ventilation is not merely a technical prescription; it commits families to nightly routines, equipment maintenance, and an enduring reminder of disease progression. Criteria that are too permissive risk imposing these burdens without benefit, while criteria that are too restrictive risk depriving children of an intervention that, when appropriately timed, can improve sleep quality, daytime functioning, and potentially survival.

The letter also underscores a broader lesson about how evidence accumulates in pediatric sleep medicine. Large randomized trials are difficult to conduct in rare diseases, and much practice has been built on observational data and expert opinion. Studies that attempt to formalize criteria, such as the Dannenberg investigation, are valuable precisely because they make the reasoning explicit and testable. Letters such as that from Munir and colleagues serve as the peer community’s quality control, pressing authors on methodology, generalizability, and clinical applicability. This dialectic, proposal followed by critique followed by refinement, is how a field gradually converges on standards that clinicians can trust and families can understand.

For clinicians caring for children with neuromuscular disease, the practical message is one of calibrated vigilance. Sleep studies should be interpreted with awareness of REM physiology, age-appropriate norms, and the limitations of single-night testing, and the decision to start ventilation should integrate polysomnographic findings with symptoms, lung function trends, and family circumstances. For researchers, the exchange highlights the need for longitudinal studies that follow children from before ventilation is initiated, tracking which criteria best predict benefit, and for harmonization of carbon dioxide measurement and scoring practices across laboratories. The Islamabad authors’ contribution, though brief in the letter format, helps keep a consequential debate honest: the numbers on a sleep report are only as meaningful as the physiology, methodology, and human context behind them. As non-invasive ventilation becomes an ever more central therapy for children with weakened breathing muscles, refining the criteria that govern its initiation is not an academic exercise but a question with lifelong consequences for the children and families at its center.

Subject of Research: Polysomnographic criteria for initiating non-invasive ventilation in children with neuromuscular diseases

Article Title: Methodological and clinical considerations for polysomnographic criteria guiding non-invasive ventilation initiation in pediatric neuromuscular diseases

Article References: Munir, A. B., Imran, H., & Faraz, N. (2026). Methodological and clinical considerations for polysomnographic criteria guiding non-invasive ventilation initiation in pediatric neuromuscular diseases. Journal of Clinical Sleep Medicine, 22(1), Article 143. https://doi.org/10.1007/s44470-026-00166-9

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00166-9

Keywords: polysomnography, non-invasive ventilation, pediatric neuromuscular disease, sleep-disordered breathing, REM-related hypoventilation, Duchenne muscular dystrophy, spinal muscular atrophy, nocturnal hypoventilation, carbon dioxide monitoring, sleep medicine, clinical criteria, ventilator initiation